262 related articles for article (PubMed ID: 20018672)
1. VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation.
Birgner C; Nordenankar K; Lundblad M; Mendez JA; Smith C; le Grevès M; Galter D; Olson L; Fredriksson A; Trudeau LE; Kullander K; Wallén-Mackenzie A
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):389-94. PubMed ID: 20018672
[TBL] [Abstract][Full Text] [Related]
2. Deletion of VGLUT2 in midbrain dopamine neurons attenuates dopamine and glutamate responses to methamphetamine in mice.
Shen H; Chen K; Marino RAM; McDevitt RA; Xi ZX
Pharmacol Biochem Behav; 2021 Mar; 202():173104. PubMed ID: 33444596
[TBL] [Abstract][Full Text] [Related]
3. Targeting VGLUT2 in Mature Dopamine Neurons Decreases Mesoaccumbal Glutamatergic Transmission and Identifies a Role for Glutamate Co-release in Synaptic Plasticity by Increasing Baseline AMPA/NMDA Ratio.
Papathanou M; Creed M; Dorst MC; Bimpisidis Z; Dumas S; Pettersson H; Bellone C; Silberberg G; Lüscher C; Wallén-Mackenzie Å
Front Neural Circuits; 2018; 12():64. PubMed ID: 30210305
[TBL] [Abstract][Full Text] [Related]
4. Enhanced sucrose and cocaine self-administration and cue-induced drug seeking after loss of VGLUT2 in midbrain dopamine neurons in mice.
Alsiö J; Nordenankar K; Arvidsson E; Birgner C; Mahmoudi S; Halbout B; Smith C; Fortin GM; Olson L; Descarries L; Trudeau LÉ; Kullander K; Lévesque D; Wallén-Mackenzie A
J Neurosci; 2011 Aug; 31(35):12593-603. PubMed ID: 21880920
[TBL] [Abstract][Full Text] [Related]
5. Glutamate corelease promotes growth and survival of midbrain dopamine neurons.
Fortin GM; Bourque MJ; Mendez JA; Leo D; Nordenankar K; Birgner C; Arvidsson E; Rymar VV; Bérubé-Carrière N; Claveau AM; Descarries L; Sadikot AF; Wallén-Mackenzie Å; Trudeau LÉ
J Neurosci; 2012 Nov; 32(48):17477-91. PubMed ID: 23197738
[TBL] [Abstract][Full Text] [Related]
6. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
[TBL] [Abstract][Full Text] [Related]
7. Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons.
Steinkellner T; Zell V; Farino ZJ; Sonders MS; Villeneuve M; Freyberg RJ; Przedborski S; Lu W; Freyberg Z; Hnasko TS
J Clin Invest; 2018 Feb; 128(2):774-788. PubMed ID: 29337309
[TBL] [Abstract][Full Text] [Related]
8. Glutamate neurons within the midbrain dopamine regions.
Morales M; Root DH
Neuroscience; 2014 Dec; 282():60-8. PubMed ID: 24875175
[TBL] [Abstract][Full Text] [Related]
9. Glutamate neurons are intermixed with midbrain dopamine neurons in nonhuman primates and humans.
Root DH; Wang HL; Liu B; Barker DJ; Mód L; Szocsics P; Silva AC; Maglóczky Z; Morales M
Sci Rep; 2016 Aug; 6():30615. PubMed ID: 27477243
[TBL] [Abstract][Full Text] [Related]
10. Midbrain Dopamine Neurons Defined by TrpV1 Modulate Psychomotor Behavior.
Serra GP; Guillaumin A; Dumas S; Vlcek B; Wallén-Mackenzie Å
Front Neural Circuits; 2021; 15():726893. PubMed ID: 34858142
[TBL] [Abstract][Full Text] [Related]
11. Particular subpopulations of midbrain and hypothalamic dopamine neurons express vesicular glutamate transporter 2 in the rat brain.
Kawano M; Kawasaki A; Sakata-Haga H; Fukui Y; Kawano H; Nogami H; Hisano S
J Comp Neurol; 2006 Oct; 498(5):581-92. PubMed ID: 16917821
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of vesicular glutamate transporter in dopamine neurons increases vulnerability to MPTP-induced neurotoxicity in mice.
Shen H; Marino RAM; McDevitt RA; Bi GH; Chen K; Madeo G; Lee PT; Liang Y; De Biase LM; Su TP; Xi ZX; Bonci A
Proc Natl Acad Sci U S A; 2018 Dec; 115(49):E11532-E11541. PubMed ID: 30442663
[TBL] [Abstract][Full Text] [Related]
13. Rewarding Effects of Optical Stimulation of Ventral Tegmental Area Glutamatergic Neurons.
Wang HL; Qi J; Zhang S; Wang H; Morales M
J Neurosci; 2015 Dec; 35(48):15948-54. PubMed ID: 26631475
[TBL] [Abstract][Full Text] [Related]
14. G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization.
Runegaard AH; Dencker D; Wörtwein G; Gether U
Neuropharmacology; 2019 Dec; 161():107663. PubMed ID: 31173760
[TBL] [Abstract][Full Text] [Related]
15. Mesocorticolimbic glutamatergic pathway.
Yamaguchi T; Wang HL; Li X; Ng TH; Morales M
J Neurosci; 2011 Jun; 31(23):8476-90. PubMed ID: 21653852
[TBL] [Abstract][Full Text] [Related]
16. Developmental and target-dependent regulation of vesicular glutamate transporter expression by dopamine neurons.
Mendez JA; Bourque MJ; Dal Bo G; Bourdeau ML; Danik M; Williams S; Lacaille JC; Trudeau LE
J Neurosci; 2008 Jun; 28(25):6309-18. PubMed ID: 18562601
[TBL] [Abstract][Full Text] [Related]
17. Restricted cortical and amygdaloid removal of vesicular glutamate transporter 2 in preadolescent mice impacts dopaminergic activity and neuronal circuitry of higher brain function.
Wallén-Mackenzie A; Nordenankar K; Fejgin K; Lagerström MC; Emilsson L; Fredriksson R; Wass C; Andersson D; Egecioglu E; Andersson M; Strandberg J; Lindhe O; Schiöth HB; Chergui K; Hanse E; Långström B; Fredriksson A; Svensson L; Roman E; Kullander K
J Neurosci; 2009 Feb; 29(7):2238-51. PubMed ID: 19228977
[TBL] [Abstract][Full Text] [Related]
18. Ventral tegmental area glutamate neurons: electrophysiological properties and projections.
Hnasko TS; Hjelmstad GO; Fields HL; Edwards RH
J Neurosci; 2012 Oct; 32(43):15076-85. PubMed ID: 23100428
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice.
Kortleven C; Fasano C; Thibault D; Lacaille JC; Trudeau LE
Eur J Neurosci; 2011 May; 33(10):1751-60. PubMed ID: 21410793
[TBL] [Abstract][Full Text] [Related]
20. VGluT2 Expression in Dopamine Neurons Contributes to Postlesional Striatal Reinnervation.
Kouwenhoven WM; Fortin G; Penttinen AM; Florence C; Delignat-Lavaud B; Bourque MJ; Trimbuch T; Luppi MP; Salvail-Lacoste A; Legault P; Poulin JF; Rosenmund C; Awatramani R; Trudeau LÉ
J Neurosci; 2020 Oct; 40(43):8262-8275. PubMed ID: 32928885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
